WallStSmart

Pure Storage Inc (PSTG)vsResMed Inc (RMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ResMed Inc generates 47% more annual revenue ($5.40B vs $3.66B). RMD leads profitability with a 27.5% profit margin vs 5.1%. RMD appears more attractively valued with a PEG of 1.39. RMD earns a higher WallStSmart Score of 70/100 (B).

PSTG

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 5.0Value: 4.7Quality: 5.3
Piotroski: 4/9Altman Z: 1.22

RMD

Strong Buy

70

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 8.7Quality: 8.3
Piotroski: 6/9Altman Z: 4.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PSTGSignificantly Overvalued (-195.4%)

Margin of Safety

-195.4%

Fair Value

$25.74

Current Price

$62.63

$36.89 premium

UndervaluedFair: $25.74Overvalued
RMDUndervalued (+14.3%)

Margin of Safety

+14.3%

Fair Value

$303.00

Current Price

$225.99

$77.01 discount

UndervaluedFair: $303.00Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PSTG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
140.6%10/10

Earnings expanding 140.6% YoY

Revenue GrowthGrowth
20.4%8/10

Revenue surging 20.4% year-over-year

RMD4 strengths · Avg: 9.5/10
Operating MarginProfitability
35.2%10/10

Strong operational efficiency at 35.2%

Altman Z-ScoreHealth
4.3410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
25.7%9/10

Every $100 of equity generates 26 in profit

Profit MarginProfitability
27.5%9/10

Keeps 28 of every $100 in revenue as profit

Areas to Watch

PSTG4 concerns · Avg: 2.8/10
Price/BookValuation
14.3x4/10

Trading at 14.3x book value

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

P/E RatioValuation
113.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

RMD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : PSTG

The strongest argument for PSTG centers on EPS Growth, Revenue Growth. Revenue growth of 20.4% demonstrates continued momentum. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.5% and operating margin at 35.2%. Revenue growth of 11.0% demonstrates continued momentum.

Bear Case : PSTG

The primary concerns for PSTG are Price/Book, Profit Margin, P/E Ratio. A P/E of 113.9x leaves little room for execution misses.

Bear Case : RMD

No major red flags identified for RMD, but monitor valuation.

Key Dynamics to Monitor

PSTG profiles as a growth stock while RMD is a mature play — different risk/reward profiles.

PSTG carries more volatility with a beta of 1.33 — expect wider price swings.

PSTG is growing revenue faster at 20.4% — sustainability is the question.

RMD generates stronger free cash flow (311M), providing more financial flexibility.

Bottom Line

RMD scores higher overall (70/100 vs 59/100), backed by strong 27.5% margins and 11.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Pure Storage Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Pure Storage, Inc. provides data storage technology and solutions in the United States and internationally. The company is headquartered in Mountain View, California.

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?